Menu
Back to Journals » Vascular Health and Risk Management » Volume 8
Review
New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 16,103 | Dovepress* | 11,514+ | 3,165 | 14,679 | |
| PubMed Central* | 4,589 | 2,453 | 7,042 | ||
| Totals | 16,103 | 5,618 | 21,721 | ||
|
*Since 25 January 2012 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar